Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · AdaptHealth (AHCO)

AdaptHealth revenue rises 5.4% to $819.8 million; net loss widens to $16.0 million

Mixed Impact 4 of 5 earnings Written later

AdaptHealth reported first-quarter 2026 net revenue of $819.8 million, up 5.4%, and raised its full-year 2026 net revenue guidance by $10 million. Net loss attributable to the company widened to $16.0 million from $7.2 million, and Adjusted EBITDA fell 5.3% to $121.2 million, so revenue gains came with lower profitability. The company also replaced its Chief Operating Officer.

Key points

  • Q1 2026 net revenue $819.8 million vs. $777.9 million; organic revenue growth 9.1%
  • Net loss attributable to AdaptHealth $16.0 million (diluted EPS -$0.12) vs. $7.2 million (-$0.05)
  • Adjusted EBITDA $121.2 million vs. $127.9 million; free cash flow negative $27.5 million
  • FY2026 net revenue guidance raised to $3.45 billion-$3.52 billion; Adjusted EBITDA ($680 million-$730 million) and free cash flow ($175 million-$225 million) guidance maintained

The filing

CompanyAdaptHealth (AHCO)
Form8-K, current report
Filed with the SECMay 5, 2026, 7:07 AM ET
Accession number0001628280-26-030120

Items reported: 2.02 Results of Operations5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 6:59 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 05, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.